GAP-independent functions of DLC1 in metastasis

David Barras1, Christian Widmann

  • 1Department of Physiology, University of Lausanne, Bugnon 7, 1005, Lausanne, Switzerland.

Cancer Metastasis Reviews
|December 17, 2013
PubMed

Insights

Deleted in liver cancer-1 (DLC1) protein loss promotes cancer metastasis. This review explores DLC1

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Metastases cause most cancer deaths, driven by increased cancer cell motility and migration.
  • Rho family GTPases regulate cell migration, and their dysregulation is common in cancer.
  • Deleted in liver cancer-1 (DLC1) is a tumor suppressor with RhoGAP activity, often lost in cancers, promoting Rho-dependent malignant cell dissemination.

Purpose of the Study:

  • To review the known and potential GAP-independent mechanisms of DLC1 tumor and metastasis suppression.
  • To elucidate alternative pathways through which DLC1 inhibits cancer cell migration, invasion, and metastasis formation.

Main Methods:

  • Literature review of studies on DLC1 function beyond its RhoGAP activity.
  • Analysis of research on DLC1's role as a scaffold protein in cancer progression.
  • Synthesis of information on DLC1's impact on cell migration, invasion, and metastasis.

Main Results:

  • DLC1 acts as a scaffold protein, engaging in alternative pathways that suppress tumor and metastasis formation.
  • These GAP-independent mechanisms contribute to inhibiting cancer cell migration and invasion.
  • Loss of DLC1 function, beyond its RhoGAP activity, facilitates cancer dissemination.

Conclusions:

  • DLC1 possesses critical tumor and metastasis suppressor functions independent of its RhoGAP activity.
  • Understanding these alternative mechanisms is crucial for developing novel anti-metastasis therapies.
  • Targeting DLC1's scaffold functions could offer new strategies to combat cancer metastasis.